BBA
Baker Bros. Advisors Portfolio holdings
AUM
$10.3B
This Quarter Return
-6.77%
1 Year Return
+63.34%
3 Year Return
+231.6%
5 Year Return
+293.68%
10 Year Return
+1,612.7%
AUM
$23.1B
AUM Growth
+$23.1B
(-13%)
Cap. Flow
-$142M
Cap. Flow
% of AUM
-0.62%
Top 10 Holdings %
Top 10 Hldgs %
80.48%
Holding
138
New
11
Increased
23
Reduced
15
Closed
12
Top Buys
| 1 |
Immunocore
IMCR
|
$107M |
| 2 |
Instil Bio
TIL
|
$97.7M |
| 3 |
TLIS
Talis Biomedical Corporation Common Stock
TLIS
|
$97.3M |
| 4 |
GBT
Global Blood Therapeutics, Inc.
GBT
|
$93.6M |
| 5 |
Design Therapeutics
DSGN
|
$43M |
Top Sells
Sector Composition
| 1 | Healthcare | 97.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Intellia Therapeutics
NTLA
$1.26B
| – | – |
-111,296
| Closed | -$6.06M |
|
127
Ovid Therapeutics
OVID
$90.3M
| – | – |
-955,690
| Closed | -$2.21M |
|
128
uniQure
QURE
$934M
| – | – |
-6,740
| Closed | -$244K |
|
129
Arcus Biosciences
RCUS
$1.22B
| – | – |
-72,709
| Closed | -$1.89M |
|
|
VXRT
130
DELISTED
Vaxart
VXRT
| – | – |
-1,398,795
| Closed | -$7.99M |
|
|
VIRX
131
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| – | – |
-53,066
| Closed | -$106K |
|
|
INFI
132
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| – | – |
-522,360
| Closed | -$1.11M |
|
|
DRNA
133
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| – | – |
-102,121
| Closed | -$2.25M |
|
|
GWPH
134
DELISTED
GW Pharmaceuticals Plc American Depositary Shares
GWPH
| – | – |
-112,897
| Closed | -$13M |
|
|
FPRX
135
DELISTED
Five Prime Therapeutics, Inc.
FPRX
| – | – |
-668,000
| Closed | -$11.4M |
|